Literature DB >> 24184424

riDOM, a cell penetrating peptide. Interaction with phospholipid bilayers.

Gabriela Québatte1, Eric Kitas2, Joachim Seelig3.   

Abstract

Melittin is an amphipathic peptide which has received much attention as a model peptide for peptide-membrane interactions. It is however not suited as a transfection agent due to its cytolytic and toxicological effects. Retro-inverso-melittin, when covalently linked to the lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (riDOM), eliminates these shortcomings. The interaction of riDOM with phospholipid membranes was investigated with circular dichroism (CD) spectroscopy, dynamic light scattering, ζ-potential measurements, and high-sensitivity isothermal titration calorimetry. riDOM forms cationic nanoparticles with a diameter of ~13nm which are well soluble in water and bind with high affinity to DNA and lipid membranes. When dissolved in bilayer membranes, riDOM nanoparticles dissociate and form transient pores. riDOM-induced membrane leakiness is however much reduced compared to that of authentic melittin. The secondary structure of the ri-melittin is not changed when riDOM is transferred from water to the membrane and displays a large fraction of β-structure. The (31)P NMR spectrum of the nanoparticle is however transformed into a typical bilayer spectrum. The Gibbs free energy of riDOM binding to bilayer membranes is -8.0 to -10.0kcal/mol which corresponds to the partition energy of just one fatty acyl chain. Half of the hydrophobic surface of the riDOM lipid extension with its 2 oleic acyl chains is therefore involved in a lipid-peptide interaction. This packing arrangement guarantees a good solubility of riDOM both in the aqueous and in the membrane phase. The membrane binding enthalpy is small and riDOM binding is thus entropy-driven.
© 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell penetrating peptide; Melittin; Peptide–membrane interaction; Pore formation; Thermodynamic; Transfection

Mesh:

Substances:

Year:  2013        PMID: 24184424     DOI: 10.1016/j.bbamem.2013.10.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Label-free discrimination of membrane-translocating peptides on porous silicon microfluidic biosensors.

Authors:  Zhen Li; Qiaohui Luo; Jianmin Wu
Journal:  Biomicrofluidics       Date:  2016-12-02       Impact factor: 2.800

2.  A retro-inverso cell-penetrating peptide for siRNA delivery.

Authors:  Anaïs Vaissière; Gudrun Aldrian; Karidia Konate; Mattias F Lindberg; Carole Jourdan; Anthony Telmar; Quentin Seisel; Frédéric Fernandez; Véronique Viguier; Coralie Genevois; Franck Couillaud; Prisca Boisguerin; Sébastien Deshayes
Journal:  J Nanobiotechnology       Date:  2017-04-28       Impact factor: 10.435

3.  Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody.

Authors:  Paola Favuzza; Elena Guffart; Marco Tamborrini; Bianca Scherer; Anita M Dreyer; Arne C Rufer; Johannes Erny; Joerg Hoernschemeyer; Ralf Thoma; Georg Schmid; Bernard Gsell; Araceli Lamelas; Joerg Benz; Catherine Joseph; Hugues Matile; Gerd Pluschke; Markus G Rudolph
Journal:  Elife       Date:  2017-02-14       Impact factor: 8.140

Review 4.  Membrane Active Peptides and Their Biophysical Characterization.

Authors:  Fatma Gizem Avci; Berna Sariyar Akbulut; Elif Ozkirimli
Journal:  Biomolecules       Date:  2018-08-22

5.  Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.

Authors:  Paola Favuzza; Simon Blaser; Anita M Dreyer; Guy Riccio; Marco Tamborrini; Ralf Thoma; Hugues Matile; Gerd Pluschke
Journal:  Malar J       Date:  2016-03-15       Impact factor: 2.979

Review 6.  Biophysical approaches for exploring lipopeptide-lipid interactions.

Authors:  Sathishkumar Munusamy; Renaud Conde; Brandt Bertrand; Carlos Munoz-Garay
Journal:  Biochimie       Date:  2020-01-21       Impact factor: 4.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.